health-wealth-bulletin Logo

Doc's note: Most investors understand that stocks move through bull and bear markets over time. But what some don't know is that within those markets, there are other important cycles to follow.

Today, Keith Kaplan, CEO of our corporate affiliate TradeSmith, explains why markets aren't just about booms and busts and how you can follow the patterns toward gains...

It was the first Big Short.

In the summer of 1929, Jesse Livermore – the most famous trader of his day – quietly reversed course.

After riding the roaring bull market for the previous year, he sensed the turn.

The headlines were still euphoric. Stocks were shattering records and pulling people from all walks of life into the stock market.

But experience had taught Livermore that it's better to sell early into strength than get caught in the downdraft.

So, as the crowd piled in, he sold all his stocks and began preparing to short the market – betting on stocks falling.

From his private "war room" in the Heckscher Building on Fifth Avenue, he began building bearish positions in overextended stocks. To keep things quiet, he used more than 100 brokers and even tracked his trades with secret chalkboard symbols no one else could decipher.

His preparations paid off... spectacularly.

By the time Black Tuesday hit on October 29, he'd made $100 million – $1.9 billion in today's money. This made him one of the richest men in the world.

And it all came down to one simple truth: Markets move in cycles. Not just boom and bust cycles, but also seasonal cycles that repeat year after year.

Some seasons reward risk. Others punish it. The key isn't constant action – it's knowing when to act.

"There's a time to go long, a time to go short, and a time to go fishing," Livermore said.

And he meant it.

During slow stretches – especially in summer – Livermore would disappear to his yacht off the coast of Montauk and fish for swordfish.

The hard part, of course, is timing these seasons.

Livermore used his instinct and his experience as one of the world's greatest traders.

My team of top data scientists and computer programmers set out to solve the same problem by running 50,000 tests a day across 33 years of stock market history.

Our Seasonality tool analyzes all that data to pinpoint the calendar dates when stocks – and even entire indexes – tend to turn.

We've found stocks that hit their seasonal inflection points with 83% back-tested accuracy.

And right now, the data is pointing to something big.

Our system is predicting a major shift in the stock market this month.

Not a crash, like in 1929. But it's the kind of bearish seasonal pattern Livermore would have watched closely – even if from the deck of his boat.

Tomorrow, I'm hosting a special online event to walk you through what's coming. I'll also show you how to profit by embracing a "rapid fire" new type of investing.

Make sure to register for that here. Once you do, you'll get free preview access to the seasonal charts our tool produces for more than 5,000 stocks and the major indexes.

Today, let's go through the latest seasonality chart for the S&P 500 Index. Pay close attention to the shift coming up at the end of the month.

Are You Ready for the Coming Market Shift?

Take a look at the chart below...

The green-shaded areas represent times when the index tends to go up. The white areas are times when the index tends to fall.

As you can see, it has been prime time for the S&P 500 since the end of June.

The June 28 to July 28 window has produced gains 15 years in a row.

Over the past 15 years, the return for the S&P 500 has dipped below 2% only five times – and it has often been much higher.

For instance, in 2016, 2020, and 2022, this seasonal window delivered a gain of more than 6%.

We're in the eye of that bullish storm now.

But following this bullish window, we get a major regime change (the circled area on the chart above). After topping out around July 28, the market tends to stumble.

Historically, the S&P 500 has fallen more than half the time over the next three months, with an average return of negative 1.8%.

Interestingly, big gains in this window – like in 2010, 2018, 2020, and 2024– have often set the stage for downside at this time during the following year, such as in 2011, 2019, and 2021.

Remember, this coming market shift isn't a reason to panic. I'm NOT recommending you step away from the market entirely.

But you do need to prepare to take profits quickly during the regime change that's coming.

That's exactly what I'll be getting into during my upcoming Seasonality event tomorrow, July 22, at 10 a.m. Eastern time.

In the meantime, take a look at the gains our current Seasonality subscribers have been able to rack up on individual stocks by combining our system's signals with the power of options trading...

  • 112% on Hasbro (HAS) calls in 10 days
  • 107% on Aon (AON) calls in 23 days
  • 124% on Booking Holdings (BKNG) calls in 15 days
  • 180% on Analog Devices (ADI) calls in 14 days
  • 248% on Intuit (INTU) calls in 15 days

No wonder it has been such a huge hit with the first group of traders who had the courage to try our Seasonality tool when we unveiled it in January.

In fact, it was one of the most successful launches we've had at TradeSmith in our 20-year history.

But we're always growing... and always improving. I'm currently collaborating with Louis Navellier of InvestorPlace on a special bonus for Seasonality subscribers. And my upcoming Seasonality event will mark the next leap forward.

When you sign up, you'll get free access to seasonality charts on the webinar website and take a closer look at the seasonality patterns for market indexes like the S&P 500 and for your favorite stocks.

See you tomorrow!

All the best,

Keith Kaplan

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David Eifrig
Dr. David Eifrig
Editor

Dr. Eifrig has one of the most remarkable resumes of anyone we know in this industry. After receiving his BA from the Carleton College in Minnesota, he went on to earn an MBA from Northwestern University’s Kellogg School of Management, graduating on the Dean’s List with a double major in finance and international business.

From there, Dr. Eifrig went to work as an elite derivatives trader at the investment bank Goldman Sachs. He spent a decade on Wall Street with several major institutions, including Chase Manhattan and Yamaichi (then known as the “Goldman Sachs of Japan”).

That’s when Dr. Eifrig’s career took an unconventional turn. Sick of the greed and hypocrisy of Wall Street... he quit his senior vice president position to become a doctor. He graduated from Columbia University’s post-baccalaureate pre-medicine program and eventually earned his MD with clinical honors from the University of North Carolina at Chapel Hill. While at med school, he was elected president of his class and admitted to the Order of the Golden Fleece (considered the highest honor given at UNC-Chapel Hill).

Dr. Eifrig also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotech company, Mirus, that was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine’s many conflicts, Dr. Eifrig began to look for ways he could talk directly with individuals and use his background to show them how to take control of their health and wealth. In 2008, he joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams, and Income Intelligence, the most comprehensive monthly review we know of the universe of income investments.

He is also the author of five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He also owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California.

Back to Top